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Background
Poorly documented self-reported drug allergy (DA) is a
frequent problem in daily clinical practice and has a
considerable impact on prescription choices. Atopy has
been described as a risk factor for drug hypersensitivity
(DH). The aim of this study was to better investigate
the cases of suspicion of DH reported by patients under-
going subcutaneous allergen-specific immunotherapy
(SCIT).
Methods
In this prospective study conducted since 2013, we
firstly evaluated the self-reported cases of DH in
patients undergoing SCIT in the Allergy Department of
our Hospital. The SCIT has been indicated to atopic
patients based on the dust mite in vivo or in vitro speci-
fic-IgE (D.pteronyssinus and/or B.tropicalis) and clinical
relevance of these allergens. We excluded cases with
unrelated history of DH. For the evaluation of suspected
DH, we used the European Network for Drug Allergy
(ENDA) questionnaire and the DA work-up followed
the ENDA recommendations.
Results
Of all 1400 patients undergoing SCIT evaluated on
May/2013, 691(49,3%) replied the first questionnaire,
133(19%) of those self-reported having drug allergies.
Forty-five (34%) indicated hypersensitivity to antibiotics
(ATB), 46(35%) to non-steroidal anti-inflammatory
drugs (NSAIDs), 5(4%) to both ATB and NSAIDs, 31
(23%) to other drugs and 6(4%) didn’t remember the
medication involved. Of the 133 reports, 65(49%) were
evaluated by ENDA questionnaire and 68(51%) refused
to go through the drug-allergy evaluation. Of those 65
evaluated cases, forty-two (65%) were women and the
mean age was 28 (4 to 70 years). Thirty (46%) cases had
history of immediate reaction and the mean time
between the reaction and the evaluation was 10 years.
Eleven (17%) cases were excluded and the DH investiga-
tion has been offered to 54(83%) patients, from whom
38(58%) had possible/probable clinical history of DH.
Twenty-five (38%) cases refused or were not interested
in undergoing the investigation and 11(17%) are still
under investigation. Of 18(28%) who completed the
investigation, 11 were with NSAIDs and 7 with antibio-
tics, all negative.
Conclusions
The major result of this study confirmed that DH reac-
tions occurred in less than one quarter of patients with
a history suggesting possible DA. Negative results on
DA work-up may have occurred due to the loss of sensi-
tization and cofactors not included in the diagnostic
procedure. Diagnostics tests in individuals with self-
reported DA can exclude these conditions.
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